NCT00314158
Completed
Phase 3
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
Overview
- Phase
- Phase 3
- Intervention
- Brinzolamide 10 mg/ml + Timolol 5 mg/ml eye drops, suspension
- Conditions
- Open-angle Glaucoma
- Sponsor
- Alcon Research
- Enrollment
- 523
- Locations
- 1
- Primary Endpoint
- Mean intra-ocular pressure (IOP)
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
The purpose of this study is to determine whether a glaucoma therapy is safe and effective in treating patients with open-angle glaucoma or ocular hypertension.
Investigators
Eligibility Criteria
Inclusion Criteria
- •18 years of age or older
- •Diagnosis of open-angle glaucoma
- •Other protocol-defined inclusion criteria may apply
Exclusion Criteria
- •Other protocol-defined exclusion criteria may apply
Arms & Interventions
Brinzolamide +Timolol
Intervention: Brinzolamide 10 mg/ml + Timolol 5 mg/ml eye drops, suspension
Brinzolamide
Intervention: Brinzolamide 10 mg/ml (AZOPT) eye drops, suspension
Timolol
Intervention: Timolol 5 mg/ml eye drops, solution
Outcomes
Primary Outcomes
Mean intra-ocular pressure (IOP)
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 3
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionOpen-angle GlaucomaOcular HypertensionNCT00314171Alcon Research437
Completed
Phase 2
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionOpen-angle GlaucomaOcular HypertensionNCT00287521Alcon Research87
Completed
Phase 3
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionOpen-angle GlaucomaOcular HypertensionNCT00293761Alcon Research109
Completed
Phase 3
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionOpen-Angle GlaucomaOcular HypertensionNCT00293800Alcon Research173
Completed
Phase 3
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionOpen-angle GlaucomaOcular HypertensionNCT00293787Alcon Research156